Government Briefs

Navy First To Fund Utah Fusion With a $400,000 grant issued earlier this month, the Office of Naval Research has become the first government agency to fund the University of Utah’s groundbreaking fusion research (See The Scientist, May 1, page 1). The grant will support additional basic research by electrochemists Stanley Pons and Martin Fleischmann “to confirm their claims [of room-temperature sustained fusion] or, if that’s not what’s going on, to get to the truth,

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

With a $400,000 grant issued earlier this month, the Office of Naval Research has become the first government agency to fund the University of Utah’s groundbreaking fusion research (See The Scientist, May 1, page 1). The grant will support additional basic research by electrochemists Stanley Pons and Martin Fleischmann “to confirm their claims [of room-temperature sustained fusion] or, if that’s not what’s going on, to get to the truth,” says ONR program manager Robert Nowak. “I’m not thinking in terms of applications,” he says. We have to think of it as a phenomenon, not a power source.” Nevertheless, Nowak says that the work funded by his office should have potential use for the Navy “20 or 30 years down the road.” ONR has been funding Pons’s work in other areas since 1979, but since 1983 the two researchers had been supporting their seminal fusion work with private funds.

A new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies